1: Chen T, Yang LK, Ai P, Zhu J, Hang CH, Wang YH. Edonerpic maleate regulates glutamate receptors through CRMP2- and Arc-mediated mechanisms in response to brain trauma. Cell Death Discov. 2022 Mar 4;8(1):95. doi: 10.1038/s41420-022-00901-0. 2: Moutal A, Shan Z, Miranda VG, François-Moutal L, Madura CL, Khanna M, Khanna R. Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief. Channels (Austin). 2019 Dec;13(1):498-504. doi: 10.1080/19336950.2019.1684608. 3: Pines AR, Sattur MG, Abi-Aad KR, Bendok BR. Edonerpic Maleate: A Promising Pharmacological Agent for Stroke Recovery. Neurosurgery. 2019 Jan 1;84(1):E3-E4. doi: 10.1093/neuros/nyy397. Alzheimer’s Disease Cooperative Study TCAD Study Group. Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2019 Nov 1;76(11):1330-1339. doi: 10.1001/jamaneurol.2019.1868.
合成参考文献
参考文献:10.14283/jpad.2022.129 摘要:16th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Symposia. The Journal of Prevention of Alzheimer's Disease. 2023 Nov;10():4–55. doi: 10.14283/jpad.2022.129. 参考文献:10.1007/978-1-0716-4494-2_2 摘要:Takahashi T. Manipulation and Imaging of Plasticity of the Glutamate Synapse for Brain Diseases in Living Human. 2025. In: Neuromethods.